Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Tischkowitz

Showing results (51-60 of 258) with videos related to

Pageof 26
Sort By:
Journal of Medical Genetics|May 12, 2017
Pathology update to the Manchester Scoring System based on testing in over 4000 familiesD Gareth Evans, Elaine F Harkness, Inga Plaskocinska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2025
Cancer and Overgrowth Manifestations of PTEN Hamartoma Tumor Syndrome: Management Recommendations from the International PHTS Consensus Guidelines Working GroupAndrew Dhawan, Sarah Baitamouni, Darren Liu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 12, 2021
Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Marc Tischkowitz, Judith Balmaña, William D Foulkes, et al.
Journal of Medical Genetics|June 24, 2020
UKCGG Consensus Group guidelines for the management of patients with constitutional <i>TP53</i> pathogenic variantsHelen Hanson, Angela F Brady, Gillian Crawford, et al.
The Lancet. Oncology|December 12, 2022
Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort studyColin Y C Lee, Adriaan Olivier, Judith Honing, et al.
British Journal of Cancer|May 31, 2023
Risk-reducing surgery for individuals with cancer-predisposing germline pathogenic variants and no personal cancer history: a review of current UK guidelinesRebecca L McCarthy, Ellen Copson, William Tapper, et al.
Genes, Chromosomes & Cancer|August 25, 2020
Pathogenic germline variants in patients with features of hereditary renal cell carcinoma: Evidence for further locus heterogeneityPhilip S Smith, Hannah West, James Whitworth, et al.
BMC Cancer|July 26, 2007
Use of immunohistochemical markers can refine prognosis in triple negative breast cancerMarc Tischkowitz, Jean-Sébastien Brunet, Louis R Bégin, et al.
Bioinformatics (Oxford, England)|November 3, 2017
pedigreejs: a web-based graphical pedigree editorTim Carver, Alex P Cunningham, Chantal Babb de Villiers, et al.
Genes, Chromosomes & Cancer|January 24, 2013
Heterozygous mutations in the PALB2 hereditary breast cancer predisposition gene impact on the three-dimensional nuclear organization of patient-derived cell linesLandon Wark, David Novak, Nelly Sabbaghian, et al.
Pageof 26

Showing results (51-60 of 258) with videos related to

Sort By:
Pageof 26
Journal of Medical Genetics|May 12, 2017
Pathology update to the Manchester Scoring System based on testing in over 4000 familiesD Gareth Evans, Elaine F Harkness, Inga Plaskocinska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2025
Cancer and Overgrowth Manifestations of PTEN Hamartoma Tumor Syndrome: Management Recommendations from the International PHTS Consensus Guidelines Working GroupAndrew Dhawan, Sarah Baitamouni, Darren Liu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 12, 2021
Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Marc Tischkowitz, Judith Balmaña, William D Foulkes, et al.
Journal of Medical Genetics|June 24, 2020
UKCGG Consensus Group guidelines for the management of patients with constitutional <i>TP53</i> pathogenic variantsHelen Hanson, Angela F Brady, Gillian Crawford, et al.
The Lancet. Oncology|December 12, 2022
Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort studyColin Y C Lee, Adriaan Olivier, Judith Honing, et al.
British Journal of Cancer|May 31, 2023
Risk-reducing surgery for individuals with cancer-predisposing germline pathogenic variants and no personal cancer history: a review of current UK guidelinesRebecca L McCarthy, Ellen Copson, William Tapper, et al.
Genes, Chromosomes & Cancer|August 25, 2020
Pathogenic germline variants in patients with features of hereditary renal cell carcinoma: Evidence for further locus heterogeneityPhilip S Smith, Hannah West, James Whitworth, et al.
BMC Cancer|July 26, 2007
Use of immunohistochemical markers can refine prognosis in triple negative breast cancerMarc Tischkowitz, Jean-Sébastien Brunet, Louis R Bégin, et al.
Bioinformatics (Oxford, England)|November 3, 2017
pedigreejs: a web-based graphical pedigree editorTim Carver, Alex P Cunningham, Chantal Babb de Villiers, et al.
Genes, Chromosomes & Cancer|January 24, 2013
Heterozygous mutations in the PALB2 hereditary breast cancer predisposition gene impact on the three-dimensional nuclear organization of patient-derived cell linesLandon Wark, David Novak, Nelly Sabbaghian, et al.
Pageof 26